[DOI] [PubMed] [Google Scholar] 68.Zhao C., Gillette D.D., Li X., Zhang Z., Wen H
"There have been a very small number of studies on glutathione on a small numbers of patients, not well conducted and not replicated we don't regard that as conclusive evidence," he said
BPC-157 at either 0.0045 mg/lb or 0.0000045 mg/lb intraperitoneally produced almost complete reversal of this supersensitivity when co-administered with haloperidol or given therapeutically afterward
They can be considered as part of a veterinarian-led plan, because liver disease can change glutathione status and oxidative balance
Disadvantages are: raising potassium, lowering BP (dizzy on standing, dehydrated), reversibly raising liver tests (need to monitor every 3 months)
Professor of Medicine Boston University School of Medicine Copyright 2001-2026 Linus Pauling Institute Figure Alternative Text Figure 1